Since its foundation in 1890, Santen Pharmaceutical Co., Ltd. has contributed to the protection and improvement of people's eyesight and health. Santen's integrated operations extend from research and development to production and sales of prescription and over-the-counter pharmaceuticals.
Today, Santen specializes in original ophthalmic and anti-rheumatic pharmaceuticals as it works to create superior pharmaceuticals for all types of ophthalmic disorders and offer information that meets clinical needs. As a result, Santen leads Japan's market for prescription ophthalmics, which represent over 80 percent of Company sales.
With marketing and development bases in Japan, the United States and Europe, backed by first-rate R&D capabilities, Santen aims to increase corporate value to become a world-class company that delivers unique products to patients worldwide.
Sales By Business
Percentage of consolidated net sales by business segment for the year
ended March 31, 2011 (Net Sales: 110,812 million yen)
Over-the-Counter (OTC) Pharmaceuticals
Since the launch of Daigaku Eye Drops in 1899, Santen has been committed to the development, production and marketing of superior OTC ophthalmic products, with a focus on basic treatment and eye disease prevention. A consistent emphasis on creativity and innovation, such as introducing Japan's first plastic eye drop container in 1962, highlights Santen's determination to put numerous innovative ideas into practice. Major OTC products include Sante FX Neo , the Sante de u series and the Sante 40 series, which have been well-recognized among Japanese consumers for many years.
Overview
Name |
Santen Pharmaceutical Co., Ltd. |
Corporate Headquarters |
9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka 533-8651, Japan TEL: +81-6-6321-7000 |
Established |
1890 |
Incorporated |
1925 |
Paid-in Capital |
6,614 million yen |
Number of Employees |
2,867 |
Representatives |
Akira Kurokawa (President & CEO) |
Stock Exchange Listings |
Tokyo and Osaka |
Business |
Research and development, production and marketing of pharmaceuticals and medical devices |
Offices, |
Nara Research and Development Center, Noto Plant, Shiga Plant, Osaka Plant, approx. 92 Marketing Offices in Japan (Tokyo Office, etc.), Beijing Representative Office |
| Subsidiaries | Japan: |
Global Operations
Santen Group Companies
Claire Co., Ltd.- 348-3, Aza-suwa, Oaza-shide, Taga-cho
Inukami-gun, Shiga 522-0314, Japan
TEL: +81-749-48-2234
FAX: +81-749-48-2239
Business: Cleaning of antidust and sterilized clothing
Equity Ownership: 100%
- Santen Holdings U.S. Inc.
- 555 Gateway Drive, Napa, California 94558, U.S.A.
Business: Holding company for North American businesses
Equity Ownership: 100%
- Santen Inc.
- 555 Gateway Drive, Napa, California 94558, U.S.A. TEL: +1-707-254-1750 FAX: +1-707-254-1755 Business: Clinical development, consignment production and marketing support of pharmaceuticals Equity Ownership: 100% *
- Advanced Vision Science, Inc.
- 5743 Thornwood Drive, Goleta, California 93117, U.S.A.
TEL: +1-805-683-3851
FAX: +1-805-964-3065
Business: Development, production and marketing of medical devices
Equity Ownership: 100% *
- Santen Oy
- Niittyhaankatu 20, P.O. Box 33, FIN-33721 Tampere, Finland
TEL: +358-3-284-8111
FAX: +358-3-318-1900
Business: Development, production and marketing of pharmaceuticals
Equity Ownership: 100%
- SantenPharma AB
- Solna torg 3, SE-17145 Solna, Sweden
TEL: +46-8-83-4140
FAX: +46-8-83-4145
Business: Marketing support of pharmaceuticals
Equity Ownership: 100%
- Santen GmbH
- Industriestrasse 1, Germering D-82110, Germany
TEL: +49-89-848078-0
FAX: +49-89-848078-60
Business: Marketing support of pharmaceuticals, regulatory affairs, scientific marketing and business development
Equity Ownership: 100%
- Taiwan Santen Pharmaceutical Co., Ltd.
- 16F, No. 57, Sec.2, Tun-Hwa South Rd., Taipei 10681, Taiwan, R.O.C.
TEL: +886-2-2700-1553
FAX: +886-2-2700-1730
Business: Import and marketing of pharmaceuticals
Equity Ownership: 100%
- Santen Pharmaceutical Korea, Co., Ltd.
- 3F, Seocho G-WELL Tower, 1678-4, Seocho-dong, Seocho-gu, Seoul 137-070, Korea
TEL: +82-2-754-1434
FAX: +82-2-754-2929
Business: Import and marketing of pharmaceuticals
Equity Ownership: 100%
- Santen Pharmaceutical (China) Co., Ltd.
- No.169 Tinglan Road, Suzhou Industrial Park, Jiangsu Province, 215026, P.R.C.
TEL: +86-512-6295-7500
FAX: +86-512-6295-7800
* Indirect investment through Santen Holdings U.S. Inc
Offices, Laboratories and Plants
- Corporate Headquarters.
- 9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku
Osaka 533-8651, Japan
TEL: +81-6-6321-7000
FAX: +81-6-6321-8400
- Nara Research and Development Center
- 8916-16, Takayama-cho, Ikoma-shi
Nara 630-0101, Japan
TEL: +81-743-79-4501
FAX: +81-743-79-4521
- Noto Plant
- 2-14,Shikinami,Houdatsushimizucho,Hakui-gun
Ishikiawa 929-1494, Japan
TEL: +81-767-29-2666
FAX: +81-767-29-4233
- Shiga Plant
- 348-3, Aza-suwa, Oaza-shide, Taga-cho
Inukami-gun, Shiga 522-0314, Japan
TEL: +81-749-48-2900
FAX: +81-749-48-2901
- Osaka Plant
- 9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku
Osaka 533-8651, Japan
TEL: +81-6-6321-9976
FAX: +81-6-6321-7149
- Beijing Representative Office
- Suit 1204,TOWER W3, Oriental Plaza
No. 1 East Chang An Ave., Dong Cheng District
Beijing City 100738, P.R.C.
TEL: +86-10-8515-1515
FAX: +86-10-8515-1020
